SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 258.2 CNY | -1.31% |
|
+18.97% | +41.60% |
| 26/04 | Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80% | MT |
| 25/04 | Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2024 * | 2.12B 292M 24.4B | Sales 2025 * | 2.68B 370M 30.89B | Capitalization | 32.17B 4.44B 371B |
|---|---|---|---|---|---|
| Net income 2024 * | 449M 62.01M 5.18B | Net income 2025 * | 669M 92.39M 7.71B | EV / Sales 2024 * | 15.2 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 12 x |
| P/E ratio 2024 * |
71.7
x | P/E ratio 2025 * |
48.1
x | Employees | 1,995 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.01% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.31% | ||
| 1 week | +18.97% | ||
| Current month | +20.64% | ||
| 1 month | +20.64% | ||
| 3 months | +75.27% | ||
| 6 months | +60.16% | ||
| Current year | +41.60% |
1 week
229.00
266.66
1 month
207.67266.66
Current year
130.00266.66
1 year
112.24266.66
3 years
56.07266.66
5 years
33.26266.66
10 years
4.42266.66
| Managers | Title | Age | Since |
|---|---|---|---|
E Gao
CEO | Chief Executive Officer | 50 | 05/00/05 |
| 37 | - | ||
Ya Nan Cheng
DFI | Director of Finance/CFO | 50 | 01/03/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiao Yan Kong
BRD | Director/Board Member | 51 | 05/01 |
Ji Dong Liu
CHM | Chairman | 67 | 05/00/05 |
E Gao
CEO | Chief Executive Officer | 50 | 05/00/05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.43% | 12 M€ | -16.71% | - | |
| 0.00% | 34 M€ | +2.43% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 258.2 | -1.31% | 3,696,547 |
| 26/24/26 | 261.6 | +4.34% | 3,701,970 |
| 25/24/25 | 250.7 | +2.21% | 3,943,373 |
| 24/24/24 | 245.3 | +5.96% | 4,451,708 |
| 23/24/23 | 231.5 | +6.69% | 4,134,369 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Companyâs main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.
Sector
Pharmaceuticals
Calendar
13/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
258.2
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +41.60% | 4.44B | |
| +3.30% | 69.85B | |
| +11.77% | 8.98B | |
| -14.44% | 4.89B | |
| +5.96% | 3.95B | |
| +22.78% | 2.49B | |
| -19.32% | 2.4B | |
| -27.04% | 2.28B | |
| +7.97% | 1.96B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 300573 Stock
